Venerdì mattina dalle ore 8.30 alle ore 9.30
La Dottoressa Silvia Vannuccini è Ricercatore a Tempo Determinato di Tipo B (RTDb), afferente al Settore Scientifico-Disciplinare MEDS-21/A – Ginecologia e Ostetricia, e specialista in Ginecologia e Ostetricia presso il Dipartimento Materno-Infantile dell’Azienda Ospedaliera Universitaria Careggi.
Ha conseguito la Laurea in Medicina e Chirurgia cum laude presso l’Università degli Studi di Siena e la Specializzazione in Ginecologia e Ostetricia presso la stessa Università. Durante la formazione, ha svolto training clinico e di ricerca presso l’Imperial College NHS Trust- Hammersmith and Queen's Charlotte's Hospital, Londra. È stata Clinical Research Fellow in Medicina Materno-Fetale presso il Women’s Centre, John Radcliffe Hospital, all’Università di Oxford, dedicandosi alla ricerca sulla crescita fetale e alla gestione delle gravidanze a rischio. Ha poi svolto attività di ricerca clinica come assegnista presso l’Università di Firenze, occupandosi della gestione delle gravidanze a rischio materno, dell’ambulatorio del parto pretermine e dell’ambulatorio delle gravidanze gemellari.
Ha inoltre un expertise nella diagnosi ecografica e nella gestione dei disordini della mestruazione, in particolare endometriosi, adenomiosi e fibromi uterini. Durante il Dottorato di Ricerca ha svolto periodi formativi e di ricerca clinica all’estero come Visiting Researcher presso l’Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Parigi e presso l’Università di Leuven, Gynecology Ultrasound Unit (Belgio). Ha quindi conseguito il titolo di Dottore di Ricerca in Medicina Molecolare presso l’Università degli Studi di Siena, con una tesi sulla relazione tra stress e endometriosi. Attualmente gestisce con il Prof Petraglia il Centro Endometriosi, Vulvodinia e Dolore Pelvico Cronico e ll’Ambulatorio Adenomiosi e Fibromi uterini dell’AOU Careggi, occupandosi della diagnostica clinica ed ecografica ginecologica e del trattamento ormonale di tali patologie.
È autrice di più di 100 pubblicazioni scientifiche su riviste internazionali e relatrice inivtata a congressi nazionali e internazionali della sua disciplina.
Curriculum Vitae et Studiorum - Dr.ssa Silvia Vannuccini, MD PhD
POSIZIONE ATTUALE
ISTRUZIONE E FORMAZIONE
2021: Dottorato di Ricerca in Medicina Molecolare (Ciclo XXXIII) - Doctor Europaeus
Dipartimento di Medicina Molecolare e dello Sviluppo, Università degli Studi di Siena
Coordinatore: Prof. Vincenzo Sorrentino
PhD Research: “Endometriosis and stress: impact on women’s health”.
Tutor: Prof. De Leo
2018: Visiting scientist
Universitair Ziekenhuis (UZ), KU Leuven, UZ Leuven -Gynaecologie en verloskunde (Leuven, Belgio)
Responsabile Prof. Dirk Timmerman - Tutor: Dr. Thierry Van den Bosch
Clinical and research topics: Ultrasound diagnosis of endometriosis and adenomyosis. Visiting researcher presso Dipartimento di Ginecologia e Ostetricia, Unità di Ginecologia e Ecografia Ginecologica per lo studio ecografico del miometrio – collaborazione progetto MUSA – ISUOG.
2018 - 2019: Visiting scientist
Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin (Parigi, Francia)
Tutor: Prof. Charles Chapron
Progetto di ricerca su adenomiosi e endometriosi e fertilità
- Adenomiosi: diagnosi clinica e di imaging
- Adenomiosi e immunità: impatto sull’impianto
- Studio ecografico e RM di adenomiosi e endometriosi
Attività clinica presso l’unità di Assistance Médicale à la Procréation (AMP) – Responsabile Prof. Pietro Santulli (Pôle Périnatalogie Periconceptologie Gynécologie, Service de Gynécologie Obstétrique et Médecine de la Reproduction, Paris, France)
2012 - 2017:Specializzazione in Ginecologia e Ostetricia
Università degli Studi di Siena, Azienda Ospedaliera Universitaria Senese
Direttore Scuola di Specializzazione: Prof. Felice Petraglia (fino al 28/02/17), Prof. Vincenzo De Leo
Titolo tesi specializzazione: “Circonferenza addominale fetale: valori di riferimento della velocità di crescita” - Relatore: Professor F.M. Severi
Voto di specializzazione: 70/70 cum laude
Programma di formazione certificato nel 2013 da European Board and College of Obstetrics and Gynecology (EBCOG).
2016 - 2017: Clinical Research Fellowship in Medicina Materno-Fetale
Nuffield Department of Obstetrics and Gynaecology Women’s Centre, John Radcliffe Hospital - University of Oxford, Oxford (UK)
Direttore: Prof. Stephen Kennedy - Supervisor: Mr Lawrence Impey
- Formazione clinica specialistica in medicina materno-fetale.
- Gestione ambulatorio del parto prematuro
- Esecuzione di >800 ecografie ostetriche di I e II livello
- Attività di ricerca sullo studio ultrasonografico della crescita fetale, nell’ambito del progetto Oxford Growth Restriction Identification Programme (OxGRIP)
- Attività di training per i sonographers (Quality Control del Doppler materno-fetale) presso Ultrasound Department
2015: Observership Placement Training in Ostetricia
Imperial College NHS Trust- Hammersmith and Queen's Charlotte's Hospital London (United Kingdom)
Periodo formativo all’estero - Supervisor: Prof Phillip Bennett
Training in Centre for Fetal Care (Prof. C. Lees), Prematurity Clinic, Diabetes Clinic, Obstetric Medicine Clinic (Prof. Nelson-Piercy), Antenatal Clinic, Labour Ward, Theatre and Early Pregnancy Assessment Unit (EPAU).
2011: Clinical and research observership training in Ostetricia e Ginecologia
Imperial College NHS Trust- Department of Surgery and Cancer- Reproductive Biology & Clinical Obstetrics & Gynaecology, London (United Kingdom)
Supervisor: Prof Phillip Bennett
Ricerca di base in Ostetricia (Parto prematuro: placenta e miometrio)
Training clinico in ostetricia e ginecologia presso Hammersmith and Queen's Charlotte's Hospital - London (UK)
2005 - 2011: Laurea in Medicina e Chirurgia cum laude
Università di Siena, Siena - Classe delle Lauree Specialistiche in Medicina e Chirurgia (46/S) D.M. 509/1999
Voto di laurea: 110/110 cum laude (Titolo conseguito in data 23/06/2011)
Tesi di Laurea: “Nuovo approccio metodologico nella diagnosi del ritardo di crescita intrauterino" (menzione di dignità di stampa)
Relatore: Professor F.M. Severi
PRECEDENTI POSIZIONI PROFESSIONALI E ACCADEMICHE
2018 – 2019: Titolare di Assegno di Ricerca con attività assistenziale di tipo autonomo
Dipartimento di Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA), Università degli Studi di Firenze
Progetto di ricerca: “Fetal and Neonatal Programming e salute dell’adulto: i primi 1000 giorni di vita” – Responsabile: Prof. Gianpaolo Donzelli
Attività clinica: gestione Ambulatori Gravidanze a Rischio (SOD Medicina Prenatale), Ambulatorio Ecografia ostetrica di I e II livello, Diagnostica ecografica patologie ginecologiche, ambulatori ginecologia presso Azienda Ospedaliera Universitaria Careggi (AOUC).
2017 – 2018: Titolare di Assegno di Ricerca con attività assistenziale di tipo autonomo
Dipartimento di Scienze della Salute, Università degli Studi di Firenze
Progetto di ricerca: “Markers biochimici e biofisici per la predizione del parto pretermine nella gravidanza multipla” – Responsabile: Prof.ssa Mariarosaria Di Tommaso
Attività clinica: gestione Ambulatori Gravidanze a Rischio (SOD Medicina Prenatale), Ambulatorio Gravidanze Gemellari, Ambulatorio Parto Prematuro, Ambulatorio Ecografia ostetrica di I e II livello, Diagnostica ecografica patologie ginecologiche presso Azienda Ospedaliera Universitaria Careggi (AOUC).
ATTIVITÀ DIDATTICA
Insegnamenti in Corsi di Laurea
v Corso di Laurea Magistrale a ciclo unico - Medicina e Chirurgia
v Corso di Laurea Magistrale Scienze infermieristiche e ostetriche
v Corso di laurea in Ostetricia (abilitante alla professione sanitaria di Ostetrica/o)
v Corso di laurea in Infermieristica (Abilitante Alla Professione Sanitaria Di Infermiere) – Sede di Empoli
Insegnamenti in Scuole di Specializzazione
Insegnamenti in Dottorati di Ricerca
Dottorato in Scienze Biomediche
Curriculum “Medicina di Genere”
Insegnamenti in Master universitari
ATTIVITÁ SCIENTIFICA
PARTECIPAZIONE, ORGANIZZAZIONE, DIREZIONE E COORDINAMENTO DI GRUPPI DI RICERCA
2015 – 2017: Co- Investigator studio clinico “Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban Therapy for Women in Spontaneous Preterm Labor” (GlaxoSmithKline)
2015- 2017: Co-investigator del progetto “Oxford Growth Restriction Identification Programme (OxGRIP)”, Oxford University Hospitals, NHS Foundation Trust
2021- 2022: Co- Investigator dello studio clinico “randomized, double-blind, open for active comparator, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of three different doses of P2X3 antagonist (BAY 1817080) versus placebo and elagolix 150 mg in women with symptomatic endometriosis” (Bayer AG)
2021 – presente: Co-investigator dello studio multicentrico “Perinatal and 2 year neurodevelopmental outcome in late preterm fetal compromise: the TRUFFLE 2 Randomised Trial”. promosso dall'Imperial College NHS Trust (Londra, UK), Chief Investigator, Christopher Lees - Responsabile locale Azienda Ospedaliera Careggi: Prof Mecacci
2023 – presente: Co-Investigator del Progetto 2022SSFN2E finanziato all’interno del Bando PRIN 2022 di cui al Decreto Direttoriale n. 104 del 02/02/2022 nell’ambito del Piano Nazionale di Ripresa e Resilienza, Missione 4 – Componente 2. Dalla Ricerca all’Impresa - Investimento 1.1 Fondo per il Programma Nazionale della Ricerca (PNR) e Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN), finanziato dall’Unione europea – NextGenerationEU – CUP B53D23020740006. PI: Prof. Federico Mecacci “The role of maternal hemodynamics in therapy of hypertensive disease of pregnancy: a randomized controlled trial”. Finanziamento di € 39.394
2022 – 2025: Principal Investigator del Progetto di ricerca finalizzata anno 2018 del Ministero della Salute "EndomeTRiosisPain Project: a preclinical and clinical investigation to assess the role of transient receptor potential ankyrin 1 (TRPA1) and TRP vanilloid 1 (TRPV1) channels and oxidative stress in the development and maintenance of pain associated with endometriosis" CODICE: GR-2018-12368352. Finanziamento 285.000 euro. Ruolo di PI da novembre 2022 a ottobre 2023 in sostituzione della dott.ssa Seravalli, poi prosecuzione come co-investigator.
2024 – presente: Principal Investigator del Progetto “PerFert - Personalisation of Treatment for Female Infertility and Recurrent Pregnancy Loss of Unknown Ethiology” presentato in risposta alla Joint Transnational Call for Proposals (2024) for “Identification or Validation of Targets for Personalised Medicine Approaches (PMTargets)” - – EP PerMed. Co-funded by The European Union. Finanziamento di 300.000 euro (finanziamento complessivo del progetto al Consortium 1.275.570euro)
Partecipazione alle attività di un gruppo di ricerca caratterizzato da collaborazioni a livello nazionale o internazionale
v Membro dell'Expert Panel on Heavy Menstrual Bleeding (HELP Group - a panel of international physicians with an expert interest in HMB, endorsed by Society of Endometriosis and Uterine Disorders (SEUD). Componenti: Joaquim Calaf, William Catherino, Jean- Philippe Estrade, Kaori Koga, Agnaldo Lopes Da Silva Filho, Sony S Singh, Xin Yang, Vannuccini S.
v Membro Society of Endometriosis and Uterine Disorders (SEUD) Abnormal Uterine Bleeding Task Force - Led by Professor Marie-Madeleine Dolmans & Professor Ayman Al-Hendy
v Membro del Expert Group on Heavy Menstrual Bleeding and Iron Deficiency Anemia - Society of Endometriosis and Uterine Disorders (SEUD)
PARTECIPAZIONE IN QUALITÀ DI RELATORE A CONGRESSI NAZIONALI E INTERNAZIONALI
Partecipazione come invited speaker a congressi internazionali
Ha partecipato come relatore a 58 congressi/corsi/masterclass internazionali di cui 20 dal 2023
16-18 Marzo 2023, Abu Dhabi, UAE
9th Congress of the Society of Endometriosis and Uterine Disorders (SEUD)
Relazioni:
“Abnormal Uterine Bleeding and uterine disorders: epidemiology, social and economic burden”
“Heavy menstrual bleeding (HMB) and adolescence”
Iron deficiency and anemia: Postpartum Hemorrhage
30 Marzo 2023, Losanna, Svizzera
Colloque de gynécologie et obstétrique - Comprendre et traiter l’adénomyose
Relazione:“Adenomyosis & nulliparity: pain, bleeding and subfertility”
3-5 Maggio 2023, Firenze
14th European Congress on Menopause and Andropause (EMAS)
Relazione:“Endometriosis and menopause”
15-16 Maggio 2023, Rhyah, Saudi Arabia
1st SEUD Forum on Iron Deficiency Anemia and uterine disorders: Impact on surgical management
Relazione: “Uterine fibroids and abnormal uterine bleeding”
1-2 Giugno 2023, Cairo, Egitto
3rd "Egyptian foundation of reproductive medicine & embryology (EFRE) conference
Relazione:
Endometriosis recurrence: prediction, prevention and management
Endometriosis and cancer: prevention and diagnosis
Important aspects of gestational diabetes
25-28 Giugno 2023, Copenhagen, Danimarca
ESHRE 39TH Annual Meeting
Symposium: “Overview of long-term Relugolix CT* for uterine fibroids”
17-18 Ottobre 2023, Siviglia, Spagna
SEUD Forum on the Modern Management of Uterine Fibroids
Relazione: “The management of AUB”
16-17 Novembre 2023, Porto, Portogallo
SEUD Masterclass: Current challenges and future solutions in endometriosis
Relazione:“Endometriosis: a new medical approach”
20-21 Novembre 2023, Firenze
SEUD Forum on Iron Deficiency Anemia and reproductive life: periconception, pregnancy and postpartum
Relazione:“Postpartum hemorrhage: uterine risk factors – a clinical case”
30 Novembre 2023, Cairo, Egitto
EFSS 29th Annual International conference of the Egyptian Fertility and Sterility Society (EFSS)
Relazione:“Current concepts in adenomyosis”
1 Novembre 2023, Amsterdam, The Netherlands
15th Congress of the European Society of Gynecology (ESG)
Relazione:“Differential diagnosis between uterine fibroids and adenomyosis”
20-21 Gennaio 2024, Dubai, UAE
9th Conference on Endometriosis and Uterine Disorders (EMEL)
Update on comorbidities associated with endometriosis
Menstrual distress as a medico-social dilemma
Ultrasound criteria in diagnosing adenomyosis
14-15 Marzo 2024, Madrid, Spagna
Side by Side for Women’s Health
Relazione: Recurrence of endometriosis and the need for long term treatment
18-20 Aprile 2024, Ginevra, Svizzera
10th Congress of SEUD | The Society of Endometriosis and Uterine Disorders (SEUD)
Endometriosis and uterine disorders: time for innovation, precision and strategy
Relazione:How to manage endometriosis associated co-morbidities - Gastrointestinal comorbidities
26 Aprile 2024, Parigi, Francia
Journée scientifique de Gynécologie de Port Royal: Endometriosis Life
Relazione: L’endométriose doit-elle être considérée comme une maladie
systémique?
21-24 Maggio 2024, India (online)
FOGSI ICOG Online Certificate Course on Endometriosis
Relazione: “GnRH antagonists in gynecology: emerging role”
29 Novembre 2024, Cairo, Egitto
EFSS 30th Annual International conference of the Egyptian Fertility and Sterility Society (EFSS)
Relazione: “New therapeutic option for managing adenomyosis”
6-7 Marzo 2025, Malaga, Spagna
2nd SEUD Masterclass: How to shorten the time to diagnosis in endometriosis
Relazione:“Comorbidities and long term consequences”
24-26 Aprile 2025, Praga, Repubblica Ceca
11th Congress of the Society of Endometriosis and Uterine Disorders (SEUD)
From adolescence to menopause: Modern management of endometriosis and uterine disorders
US and perimenopausal endometriosis
Gynecological disorders and Young Age Women (YAW) athletes
Endometriosis: understanding the benefits of correct medical treatment on patients’ lives
Why early endometriosis diagnosis is essential?
20 Luglio 2025, online course
ISUOG Course – Ultrasonography in infertile women
Relazione: “Fibroids in infertile women: role of ultrasound”
Partecipazione come invited speaker a congressi nazionali
Ha partecipato come relatore a 44 congressi/convegni/corsi nazionali di cui 18 dal 2023
10 Marzo 2023, Modena
Congresso “Abnormal Uterine Bleeding: dal sintomo alla terapia”
Relazione: “Adenomiosi e infertilità”
24 Marzo 2023, Firenze
2nd International Florence Forum on Gynecology – Myometrium: from benign to malignant disorders
Relazione: “Symptoms and ultrasound for adenomyosis”
19-20 Maggio 2023, Montecatini Terme
Corso "La Diagnosi e il Counselling post-ecografico nei quadri di più frequente patologia ostetrica e ginecologica - Dopo la diagnosi, una corretta gestione"
Relazione: “La diagnosi ecografica di adenomiosi e di adenomioma: quale terapia medica nella donna
sintomatica e quando è indicata la chirurgia”
9 Giugno 2023, Bari
Congresso "Endometriosis and Reproduction: An Up-Date" - Bari
Relazione: “Trattamento Medico per le Varie Forme Di Endometriosi - Antiormoni e antagonisti”
15-16 Giugno 2023, Pescara
Giornate Abruzzesi di Ginecologia dell’Infanzia e dell’Adolescenza. Dall’infanzia all’adolescenza: percorsi di prevenzione e cura
Relazione: “Endometriosi e gravidanza”
28-29 Settembre 2023, Firenze
#SIMPPERILCONFRONTO - Il Parto: La Necessità Di Una Squadra, Il Privilegio Di Una Passione - Dal basso rischio ostetrico alla gestione dell’alta complessità
Relazione: “Caso clinico su gravidanza in età avanzata, fattore di rischio uterino, accretismo placentare”
10-11 Novembre 2023, Brescia
Congresso “Patologie endocrino-ginecologiche: stato dell’arte e nuove tecniche, dalla ricerca alla pratica clinica”
Relazione:“Quando la pillola con estetrolo risponde alle esigenze delle pazienti”
1 Dicembre 2023, Siena
Congresso “Adenomiosi e sanguinamenti uterini anomali”
Relazione:“Heavy menstrual bleeding in adolescenza”
11-13 Dicembre 2023, Milano
GYN Factory – build the future together
Relazione: “Eziopatogenesi delle diverse patologie uterine”
8-9 Aprile 2024, Firenze
1° Corso Nazionale Day Therapy: Valenze terapeutiche dei contraccettivi ormonali
16-18 Maggio 2024, Maratea
XV Biennal Meeting “Daniel Dargent” – Resp. Scientifico Sergio Schettini
24 Settembre 2024, Firenze
Corso SIGO Young – Contraccezione
Relazione: “I contraccettivi ormonali sono utili anche per la terapia di patologie ginecologiche”
1 Ottobre 2024, Firenze
Corso SIGO Young – Infertilità
Relazione: “Infertilità e fibromi uterini: dalla terapia medica alla chirurgia?”
3-6 Novembre 2024, Firenze
99° Congresso nazionale Società Italiana di Ginecologia e Ostetricia (SIGO)
Relazione: “Terapie mediche per l’endometriosi”
24-25 Febbraio 2025, Firenze
2°Corso Nazionale Day Therapy – Le terapie ormonali e la salute della donna
Relazione: “Caso clinico sull’utilizzo degli antagonisti del GnRH”
14 Maggio 2025, Modena
Endometriosi & Friends – Endometriosi, fertilità e fisiopatologia ostetrica
Relazione: Nuove frontiere di terapia medica per l’endometriosi
9 Giugno 2025, Firenze
Percorso diagnostico-terapeutico dell’infertilità
Relazione: “Gestione delle patologie annessiali benigne”
28 Giugno 2025, Firenze
Pain & Personality
Relazione: Endometriosi e temperamento.
CONSEGUIMENTO DI PREMI E RICONOSCIMENTI NAZIONALI E INTERNAZIONALI
v ASN 2023/2025 - Conseguimento dell’Abilitazione Scientifica Nazionale alle funzioni di professore universitario di Prima Fascia nel Settore Concorsuale 06/H1 - GINECOLOGIA E OSTETRICIA, raggiungendo i 3 valori soglia bibliometrici e risultando in possesso di 5 titoli aggiuntivi tra quelli individuati e definiti dalla Commissione. La validità dell’Abilitazione è di dodici anni a decorrere dal 18/07/2025 con scadenza il 18/07/2037.
v ASN 2021/2023 - Conseguimento dell’Abilitazione Scientifica Nazionale alle funzioni di professore universitario di Seconda Fascia nel Settore Concorsuale 06/H1 - GINECOLOGIA E OSTETRICIA, raggiungendo i 3 valori soglia bibliometrici e risultando in possesso di 4 titoli aggiuntivi tra quelli individuati e definiti dalla Commissione. La validità dell’Abilitazione è di dodici anni a decorrere dal 13/02/2023 con scadenza il 13/02/2035
v Membro del Direttivo Nazionale SIGO Young - Società Italiana di Ginecologia e Ostetricia. Collaborazione ad attività formative e di ricerca per giovani under 35 (SIGO Young Contraccezione, SIGO Young Riproduzione)
v Membro del Gruppo di Interesse Speciale Specifico (GISS) su Adenomiosi – Società Italiana di Ginecologia e Ostetricia (SIGO) Stesura di una collana sullo stato dell'arte su adenomiosi uterina (Collana SIGO 2023, Aspetti di ginecologia benigna) e programmazione linee di ricerca su adenomiosi. Membri del panel: Sergio Schettini (Coordinatore del GISS-SIGO su Adenomiosi), Luigi Cobellis, Stefano Guerriero, Lucia Lazzeri, Lucia Manganaro, Ludovico Muzii, Maria Laura Pisaturo, Silvia Vannuccini, Errico Zupi, Nicola Colacurci.
v Associate Faculty Member - Diabetes & Endocrinology – Reproductive Endocrinology & Infertility, Faculty Opinions
v Membro dell'Expert Panel on Heavy Menstrual Bleeding (HELP Group)
v Honorary member of the Advisory Board of the Egyptian Foundation of Reproductive Medicine (EFRE)Per il contributo scientifico e didattico per la società nel campo della Medicina della Riproduzione (collaborazione per webinar, educational programs, live courses)
v Referente regionale (Regione Toscana) della International Society of Dietary Supplements and Phytotherapy (ISDSP) Scopo: promozione dell'uso corretto di integratori alimentari e fitoterapici nella dieta giornaliera e nella pratica clinica in ginecologia e ostetricia https://isdsp.it/referenti-regionali/
v Membro del programma ORBIS, un’iniziativa internazionale di mentoring rivolta a giovani medici specializzati in medicina riproduttiva, che offre un'opportunità di crescita professionale attraverso un percorso di formazione, al fine di sviluppare competenze avanzate in ambito scientifico e clinico (public speaking, leadership, statistica medica, medical writing).
PRODUZIONE SCIENTIFICA
- numero totale citazioni: 3123 (Scopus)
- H index 25 (fonte Scopus)
Numero medio di citazioni per pubblicazione: 51
IDENTIFICATIVI
- ORCID ID: 0000-0001-5790-587X
- Scopus Author ID: 55386870400
- Web of Science ResearcherID: J-8927-2019
PUBBLICAZIONI
Autrice di 112 articoli pubblicati su riviste peer-reviewed e indicizzate, di cui 38 pubblicati dal 2023
The challenge of endometriosis for female sexual health. Vannuccini S, Maseroli E, Vignozzi L, Petraglia F. J Sex Med. 2023 Feb 27;20(3):240-246. doi: 10.1093/jsxmed/qdad004.
Epigenetics, endometriosis and sex steroid receptors: An update on the epigenetic regulatory mechanisms of estrogen and progesterone receptors in patients with endometriosis. Rossi M, Seidita I, Vannuccini S, Prisinzano M, Donati C, Petraglia F. Vitam Horm. 2023;122:171-191. doi: 10.1016/bs.vh.2023.01.007.
Endometriosis and the diagnosis of different forms of migraine: an association with dysmenorrhoea. Pasquini B, Seravalli V, Vannuccini S, La Torre F, Geppetti P, Iannone L, Benemei S, Petraglia F. Reprod Biomed Online. 2023 Apr 7:S1472-6483(23)00207-9. doi: 10.1016/j.rbmo.2023.03.020
Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set. Cooper NAM, Rivas C, Munro MG, Critchley HOD, Clark TJ, Matteson KA, Papadantonaki R, Yorke S, Tan A, Bofill Rodriguez M, Bongers M, Al-Hendy A, Bahamondes L, Connolly A, Farquhar C, Gray Valbrun T, Hickey M, Taylor HS, Toub D, Vannuccini S, Iliodromiti S, Khan K. BJOG. 2023 Oct;130(11):1337-1345. doi: 10.1111/1471-0528.17473.
The HOPE study: evaluating the impact of an online educational resource for heavy menstrual bleeding on the patient-physician dynamic. Silva Filho AL, Catherino WH, Estrade JP, Koga K, Singh SS, Vannuccini S, Yang X, Lahav A, Caetano C, Calaf J. Women Health. 2023 May-Jun;63(5):370-382. doi: 10.1080/03630242.2023.2220806.
The menstrual distress questionnaire (MEDI-Q): reliability and validity of the English version. Cassioli E, Rossi E, Melani G, Faldi M, Rellini AH, Wyatt RB, Oester C, Vannuccini S, Petraglia F, Ricca V, Castellini G. Gynecol Endocrinol. 2023 Jun 19;39(1):2227275. doi: 10.1080/09513590.2023.2227275.
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation. Seidita I, Tusa I, Prisinzano M, Menconi A, Cencetti F, Vannuccini S, Castiglione F, Bruni P, Petraglia F, Bernacchioni C, Rovida E, Donati C. FASEB J. 2023 Aug;37(8):e23061. doi: 10.1096/fj.202300323R.
A 10-Year Observational Study on Twin Pregnancy: Role of Fetal Sex Pairing on Obstetric Outcome. Vannuccini S, Bolzonella S, Colucci C, Nicchi C, Strambi N, Di Tommaso M. Twin Res Hum Genet. 2023 Sep 14:1-7. doi: 10.1017/thg.2023.38
Endometriosis and sexual disorders: the effect of surgical and medical treatment, a multicentre cross-sectional study. Capezzuoli T, Maseroli E, Barra F, Vannuccini S, Vignozzi L, De Mitri P, Baggio S, Ceccaroni M, Petraglia F. F1000Res. 2023 Oct 31;12:1424. doi: 10.12688/f1000research.141537.1.
Recurrence of Uterine Fibroids After Conservative Surgery or Radiological Procedures: a Narrative Review. Capezzuoli T, Aslan B, Vannuccini S, Orlandi G, La Torre F, Sorbi F, Fambrini M, Petraglia F. Reprod Sci. 2024 May;31(5):1171-1178. doi: 10.1007/s43032-023-01418-2
Sphingosine 1-phosphate signaling axis mediates neuropeptide S-induced invasive phenotype of endometriotic cells. Prisinzano M, Bernacchioni C, Seidita I, Rossi M, Raeispour M, Cencetti F, Vannuccini S, Fambrini M, Petraglia F, Bruni P, Donati C. FEBS J. 2024 Apr;291(8):1744-1758. doi: 10.1111/febs.17071.
Adenomyosis diagnosis among adolescents and young women with dysmenorrhoea and heavy menstrual bleeding. Vannuccini S, Meleca C, Toscano F, Mertino P, Pampaloni F, Fambrini M, Bruni V, Petraglia F. Reprod Biomed Online. 2024 May;48(5):103768. doi: 10.1016/j.rbmo.2023.103768.
An update for endometriosis management: a position statement. Petraglia F, Vannuccini S, Santulli P, Marcellin L, Chapron C. J Endometr Uter Disord. 2024 Jun;6: 100062. doi:10.1016/j.jeud.2024.100062
Abnormal uterine bleeding: The well-known and the hidden face. Leal CRV, Vannuccini S, Jain V, Dolmans MM, Di Spiezio Sardo A, Al-Hendy A, Reis FM. J Endometr Uterine Disord. 2024 Jun;6:100071. doi: 10.1016/j.jeud.2024.100071.
Imaging and molecular features of adenomyosis after menopause. Vannuccini S, Gabbrielli S, Castiglione F, Nardi E, Rossi M, Orlandi G, Wu E, Bertoli F, Miele V, Donati C, Petraglia F. Maturitas. 2024 Jul;185:107996. doi: 10.1016/j.maturitas.2024.107996.
The modern management of uterine fibroids-related abnormal uterine bleeding. Vannuccini S, Petraglia F, Carmona F, Calaf J, Chapron C. Fertil Steril. 2024 Jul;122(1):20-30. doi: 10.1016/j.fertnstert.2024.04.041.
Clinical signs and diagnosis of fibroids from adolescence to menopause. Mension E, Carmona F, Vannuccini S, Chapron C. Fertil Steril. 2024 Jul;122(1):12-19. doi: 10.1016/j.fertnstert.2024.05.003.
Conservative surgical treatment for adenomyosis: New options for looking beyond uterus removal. Capezzuoli T, Toscano F, Ceccaroni M, Roviglione G, Stepniewska A, Fambrini M, Vannuccini S, Petraglia F. Best Pract Res Clin Obstet Gynaecol. 2024 Jul;95:102507. doi: 10.1016/j.bpobgyn.2024.102507
An update on the management of uterine fibroids: personalized medicine or guidelines? Mension E, Calaf J, Chapron C, Dolmans MM, Donnez J, Marcellin L, Petraglia F, Vannuccini S, Carmona F. J Endometr Uter Disord. 2024 Sept;7: 100080. doi:10.1016/j.jeud.2024.100080
Iron deficiency anemia: preconceptional, pregnancy and postpartum management – a call for action. Petraglia F, Gallone A, Sieroszewski P, Pulanic D, Marton I, Calda P, Mikulasek L, Zdanowicz J, Belci D, Vannuccini S, Critchley H. J Endometr Uter Disord. 2024 Sept;7:100079. doi:10.1016/j.jeud.2024.100079
Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosis. Titiz M, Landini L, Souza Monteiro de Araujo D, Marini M, Seravalli V, Chieca M, Pensieri P, Montini M, De Siena G, Pasquini B, Vannuccini S, Iannone LF, Cunha TM, Brancolini G, Bellantoni E, Scuffi I, Mastricci A, Tesi M, Di Tommaso M, Petraglia F, Geppetti P, Nassini R, De Logu F. Nat Commun. 2024 Nov;15(1):10142. doi: 10.1038/s41467-024-54486-6.
Long-term treatment for endometriosis with dienogest: efficacy, side effects and tolerability. La Torre F, Vannuccini S*, Toscano F, Gallucci E, Orlandi G, Manzi V, Petraglia F. Gynecol Endocrinol. 2024 Dec;40(1):2336121. doi: 10.1080/09513590.2024.2336121.
Menstrual distress in women with eating disorders: insights from the Menstrual Distress Questionnaire (MEDI-Q). Rossi E, Cassioli E, Cordasco VZ, Caiati L, Rinaldo A, Tarchi L, Dani C, Vannuccini S, Petraglia F, Ricca V, Castellini G. Arch Womens Ment Health. 2024 Nov 30. doi: 10.1007/s00737-024-01542-1.
Endometriotic lesions express microRNAs that potentially regulate the transcription of hydroxysteroid 17 beta dehydrogenase 2 (HSD17B2): a pilot study. Coutinho LM, Bernacchioni C, Casalechi M, Vannuccini S, Francisco AMC, Petraglia F, Reis FM. J Endometr Uter Disord. 2024 Dec;8:100093. doi:10.1016/j.jeud.2024.100093
Selective progesterone receptor modulators for the treatment of dysmenorrhea: an update. Speciale AR, Ozpinar K, Giani M, Tureli D, Fambrini M, Vannuccini S, Petraglia F. Expert Opin Pharmacother. 2025 Feb;26(3):257-264. doi: 10.1080/14656566.2025.2451145.
Elective uterine preservation: a novel concept to tackle reproductive ageing. Fertility preservation beyond ovaries. Di Spiezio Sardo A, Becker CM, Vannuccini S, Verguts J, Estadella Tarriel J, Suvitie PA, Guerra S, Renner SP, Garcia Velasco JA. Reprod Biomed Online. 2024 Nov 10;50(5):104704. doi: 10.1016/j.rbmo.2024.104704.
Diet characteristics in patients with endometriosis. Ruotolo A, Vannuccini S, Capezzuoli T, Pampaloni F, Cecere S, Gallucci E, Petraglia F. J Endometr Uter Disord. 2025 Mar;9:100094. doi:10.1016/j.jeud.2024.100094
Health related quality of life in individuals with endometriosis and mental health symptoms: a scoping review. Colombo GE, Vijayanathan S, Breton Z, Kvaskoff M, Sediqzadah S, Vannuccini S, Sriranjan J, Jayesh T, Gholiof M, Leonardi M. J Endometr Uter Disord. 2025 Mar;9:100105. doi:10.1016/j.jeud.2024.100105
Efficacy and safety of hormone therapies for treating adenomyosis-associated pelvic pain: a systematic review and network meta-analysis of randomized controlled trials. Etrusco A, Agrifoglio V, D'Amato A, Chiantera V, Laganà AS, Haydamous J, Cobellis L, De Franciscis P, Vannuccini S, Krentel H, Naem A, Riemma G. Front Endocrinol (Lausanne). 2025 Mar 17;16:1571727. doi: 10.3389/fendo.2025.1571727.
Management of women with endometriosis in the 21st century. Di Spiezio Sardo A, Becker CM, Renner SP, Suvitie PA, Tarriel JE, Vannuccini S, Garcia Velasco JA, Verguts J, Mercorio A. Curr Opin Obstet Gynecol. 2025 Apr 10;37(3):149-57. doi: 10.1097/GCO.0000000000001027
Human Leukocyte Antigen Haplotypes Predisposing to Celiac Disease in Patients With Endometriosis. Vannuccini S, Manzi V, Tarocchi M, Donati N, La Torre F, Toscano F, Calabrò AS, Petraglia F. Am J Reprod Immunol. 2025 Apr;93(4):e70079. doi: 10.1111/aji.70079.
Adenomyosis: the missed disease. Santulli P, Vannuccini S, Bourdon M, Chapron C, Petraglia F. Reprod Biomed Online. 2025 Apr;50(4):104837. doi: 10.1016/j.rbmo.2025.104837.
Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2. Catherino WH, Al-Hendy A, Zaim S, Bouzegaou N, Venturella R, Stewart EA, Wu R, Vannuccini S, Perry JS, Rakov VG, Munro MG. Fertil Steril. 2025 May 2:S0015-0282(25)00251-1. doi: 10.1016/j.fertnstert.2025.04.037.
Iron deficiency anemia and uterine disorders: impact on surgical management. Arab H, Bukhari ME, Alkhamis WH, Albadawi IA, Al Shukri M, Angioni S, Chahine RH, Vannuccini S, Chapron C. J Endometr Uter Disord. 2025 Jun;10:100112. doi:10.1016/j.jeud.2025.100112
Expression of cannabinoid receptors CB1, CB2 and GPR18 in adenomyotic lesions. Prisinzano M, Raeispour M, Rossi M, Seidita I, Vannuccini S, Fambrini M, Nardi E, Castiglione F, Petraglia F, Bernacchioni C, Donati C. J Endometr Uter Disord. 2025 Jun;10: 100111. doi:10.1016/j.jeud.2025.100111
Medical treatment for adenomyosis: long term use of progestins. Vannuccini S, La Torre F, Toscano F, Speciale AR, Giani M, Tureli D, Manzi V, Gallone A, Petraglia F. Gynecol Endocrinol. 2025 Dec;41(1):2511329. doi: 10.1080/09513590.2025.2511329.
Systemic comorbidities in patients with adenomyosis. Gallone A, Vannuccini S*, Manzi V, La Torre F, Toscano F, Giani M, Fambrini M, Chedraui P, Petraglia F. Reprod Biomed Online. 2025. doi:10.1016/j.rbmo.2025.02.015
Endometriosis and fibromyalgia co occurrence: a comparative study of patient history and clinical profile. Manzi V, Vannuccini S, Nacci F, Mauro I, Gallone A, Giani M, Guiducci S, Petraglia F. J Endometr Uter Disord. 2025;11. doi:10.1016/j.jeud.2025.100107
Capitoli in volumi internazionali
Autrice di 15 capitoli di libri internazionali di cui 2 pubblicati dal 2023
“The Epidemiology of Infertility in Women with endometriosis” Capezzuoli T., Sorbi F., Vannuccini S., Clarizia R., Ceccaroni M., Petraglia F. (2024) In Endometriosis-related Infertility: A Comprehensive Manual, pp. 9 – 17 Springer International PublishingDOI: 10.1007/978-3-031-50662-8_2
“Endometriosis and Adenomyosis” Vannuccini S., Aslan B., Petraglia F. (2024) In International Society of Gynecological Endocrinology Series, Part F2958, pp. 105 - 118, Springer Nature DOI: 10.1007/978-3-031-55300-4_9
Libri a diffusione nazionale
Collana SIGO 2023 - Volume 1 ASPETTI DI GINECOLOGIA BENIGNA - ADENOMIOSI - 2023 EDRA
Stesura come assistente Editore del libro - Manuale di Ginecologia e Ostetricia - 2025 – EDIZIONI MINERVA MEDICA – Editori: Felice Petraglia, Rossella Nappi, Roberto Tozzi
ATTIVITÀ EDITORIALE
Membro Comitati Editoriali
- Reproductive Health (Associate Editor)
- Clinical and Experimental Obstetrics & Gynecology (Associate Editor)
- Journal of Endometriosis and Pelvic Pain Disorders (Editorial Board Member)
- Journal of Endometriosis and Uterine Disorders (JEUD) (Editorial Board Member)
- Frontiers in Reproductive Health (Guest Associate Editor)
- Frontiers in Gynecology (Review Editor)
- Frontiers in Developmental Endocrinology (Review Editor)
Attività come reviewer per le riviste:
- American Journal of Obstetrics and Gynecology
- BMC Pregnancy and Childbirth
- BMC Microbiology
- Endocrine
- Fertility and Sterility
- Frontiers in Surgery
- Frontiers in Endocrinology
- Frontiers in Reproductive Health
- Frontiers in Medicine
- Gynecological Endocrinology
- Gynecologic and Obstetric Investigation
- Human Reproduction
- Human Reproduction Open
- Journal of Endocrinological Investigation
- Journal of Endometriosis and Pelvic Pain Disorders
- Journal of Pregnancy
- Journal of Ultrasound in Medicine
- Journal of Women’s Health
- Molecular Biology Reports
- Placenta
- Reproductive Sciences
- Reproductive Biomedicine Online
- Reproductive Biology and Endocrinology
- Scientific Reports – Nature
- Ultrasound in Medicine
ATTIVITÁ CLINICA
Conoscenza delle lingue
Madrelingua: Italiano
Ottima conoscenza di:
- inglese (IELTS – Academic module Overall band score: 7.5 - CEFR Level: C1, proficient user - advanced - Report Form number: 1762000101VANS352A (22/04/2017)
- francese (Diplôme d'études en langue française (DELF) B1 Certification) – iscritta ordine dei medici francesi (Ordre des Médicins de Paris - RPPS:10101767878)
Legenda
She is Assistant Professor in Obstetrics and Gynecology at University of Florence and Consultant in ObGyn at Careggi University Hospital in Florence, Italy. Her scientific interest is devoted to uterine disorders (endometriosis, adenomyosis and uterine fibroids), the imaging diagnosis and the medical management.
She has been trained in University of Siena as a specialist in Obstetrics and Gynecology. She worked as a clinical research fellow in Maternal Medicine at University of Oxford. During her PhD program, she focused her interest on uterine disorders (endometriosis, adenomyosis and uterine fibroids), the imaging diagnosis and the medical management, attending centres of Excellence for Endometriosis and Adenomyosis (Centre Hospitalier Universitaire (CHU) Cochin, Service de Gynécologie Obstétrique et Médecine de la Réproduction, Paris, France; KU Leuven, UZ Leuven - Gynecology Ultrasound Unit (Leuven, Belgium).
She regularly attends scientific meeting as invited speaker, on the field of Benign Gynecology and Maternal-Fetal Medicine. She is author or co-author of more than 100 peer reviewed papers published in indexed scientific journals and book chapters in international books in Obstetrics and Gynecology.
Silvia Vannuccini, M.D. PhD
CURRENT POSITION
1 Mar 2023 - present
Assistant Professor of Obstetrics and Gynecology – University of Florence Department of Experimental and Clinical Biomedical Sciences “Mario Serio”
Consultant - Specialist in Obstetrics and Gynecology - Careggi University Hospital, Florence, Italy
- National Scientific Qualification as Associate Professor (2023) and Full Professor (2025)
EDUCATION
28 Sept 2017 – 20 May 2021
PhD in Molecular Medicine – Doctor Europaeus
Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy. Supervisor: Prof. Vincenzo De Leo - Prof. Felice Petraglia.
PhD Research: “Endometriosis and stress: impact on women’s health
5 Jul 2012– 13 Jul 2017
Residency in Obstetrics & Gynecology
University of Siena, Siena (Italy) - Head of the Department: Prof. Felice Petraglia, MD
Thesis: “Abdominal circumference growth velocity reference values”
Five-years training program (certified as a Basic Training Center by European Board and College of Obstetrics and Gynecology (EBCOG) in 2013)
11 Oct 2005–23 Jun 2011
Medical School Graduation
University of Siena, Siena (Italy) Graduation mark: 110/110 cum laude
Graduation thesis: “Fetal growth restriction: a new methodologic approach"
POSTGRADUATE TRAINING: FELLOWSHIP AND INTERNSHIP
1 Nov 2019 – 28 Apr 2019
Visiting Researcher
Supervisor Prof. Charles Chapron
Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Pôle Périnatalogie Periconceptologie Gynécologie, Service de Gynécologie Obstétrique et Médecine de la Reproduction, Paris, France.
Clinical and reseach project on adenomyosis and endometriosis diagnosis by imaging; adenomyosis and fertility; adenomyosis and immunity.
Clinical activity as faisant fonction d’interne (FFI) in Assistance Médicale à la Procréation (AMP) Unit – Chief : Prof. Pietro Santulli, performing more than 500 ultrasound scans for infertility work-up, especially for endometriosis and adenomyosis.
14 Nov 2018 – 28 Nov 2018
Visiting researcher
Supervisors: Prof. Dirk Timmerman - Dr. Thierry Van den Bosch
Universitair Ziekenhuis (UZ), KU Leuven, UZ Leuven - Gynaecologie en verloskunde, Gynecology Ultrasound Unit (Leuven, Belgium)
Clinical and research topics: Ultrasound diagnosis of endometriosis and adenomyosis. Collaboration for MUSA project: ultrasound evaluation of myometrium.
1 Oct 2016 – 2 Jun 2017
Clinical Research Fellowship in Maternal-Fetal Medicine
Chair: Prof. Stephen Kennedy - Supervisor: Mr Lawrence Impey
Nuffield Department of Obstetrics and Gynaecology, Women’s Centre, John Radcliffe Hospital, University of Oxford, Oxford (UK)
Clinical and research topics: Oxford Growth Restriction Identification Programme (OxGRIP), ultrasound evaluation of fetal growth. Specific training on Fetal Medicine, with more than 1000 scans performed.
7 Sep 2015 – 31 Dec 2015
Observership Placement Training
Supervisor: Prof Philllip Bennett
Imperial College NHS Trust, Hammersmith and Queen's Charlotte's Hospital, London (UK)
22 Aug 2011–14 Oct 2011
Clinical and Laboratory Internship
Supervisor Prof Philllip Bennett Imperial College NHS Trust, Hammersmith and Queen's Charlotte's Hospital Institute of Reproductive and Developmental Biology, Department of Surgery and Cancer, Imperial College, London, UK.
Basic science project on mechanisms of preterm myometrial contractility: role of inflammation. Clinical reaining in obstetrics and gynecology.
PREVIOUS PROFESSIONAL POSITIONS AND ACADEMIC APPOINTMENTS
29 Apr 2019 – 28 Feb 2023
Consultant - Specialist in Obstetrics and Gynecology (Hospital Staff) - Careggi University Hospital, Florence, Italy
1 Oct 2018 – 28 Apr 2019
Clinical Research Assistant
Department of Neuroscience, Psychology, Pharmacology and Child Health (NEUROFARBA), University of Florence, Careggi University Hospital, Florence, Italy
1 Year Grant for Research project: “Fetal and neonatal programming and adults’ health: the first 1000 days of life” Supervisor: Prof. Gianpaolo Donzelli
Clinical activity in Maternal-Fetal Medicine Unit, Obstetric and Gynecological Ultrasound Unit
1 Sept 2017 – 31 Aug 2018
Department of Health Science, University of Florence, Careggi University Hospital, Florence, Italy
1 Year Grant for Research project: “Biochemical and biophysical markers for preterm birth prediction in twin pregnancy” Supervisor: Prof. Maria Rosaria Di Tommaso
BOARD CERTIFICATION AND MEDICAL LICENSURE
2012 Registration to the Italian Medical Council (Ordine dei Medici di Siena): n.4633
2019 Registration to French Medical Council (Ordre des Médicins de Paris)
identifiant RPPS:10101767878
TEACHING EXPERIENCE
2018-present Master di I livello
“Diagnostica clinica, strumentale e di laboratorio a supporto delle decisioni dell’ostetrica/o, University of Florence
2019-present Master di II livello in Andrologia, Medicina della Sessualità e della Riproduzione
University of Florence
2020-present Master di I livello in Biologia e Tecniche della Riproduzione, University of Florence
2020-present Master di I livello in Comunicazione Medico-Scientifica e dei Servizi Sanitari"
2021- present Master di I livello in salute riproduttiva, tecniche endoscopiche e Procreazione
Medicalmente Assistita. University of Florence
2023 – present Corso di Laurea in Medicina e Chirurgia (Medical School), University of Florence
2023 – present Corso di Laurea in Ostetricia (Midwifery School), University of Florence
2023 – present Residency Program in Obstetrics and Gynecology, University of Florence
2023 – present Corso di Laurea in Infermieristica (Nursing School), University of Florence
2023 – present Corso di Laurea Magistrale in Scienze Infermieristiche e Ostetriche, University of Florence
SCIENTIFIC ACTIVITY
Responsible for the scientific coordination of national and international research projects funded through competitive, peer-reviewed calls or participation to national or international research groups.
2015-2017
2016-2017
Co- Investigator “Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban Therapy for Women in Spontaneous Preterm Labor” (GlaxoSmithKline)
Co-investigator “Oxford Growth Restriction Identification Programme (OxGRIP)”, Oxford University Hospitals, NHS Foundation Trust
2021-2022
Co- Investigator “Randomized, double-blind, open for active comparator, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of three different doses of P2X3 antagonist (BAY 1817080) versus placebo and elagolix 150 mg in women with symptomatic endometriosis” (Bayer AG)
2021- present
Co-investigator “Perinatal and 2 year neurodevelopmental outcome in late preterm fetal compromise: the TRUFFLE 2 Randomised Trial”
2022 – present
Principal Investigator“EndomeTRiosisPain Project: a preclinical and clinical investigation to assess the role of transient receptor potential ankyrin 1 (TRPA1) and TRP vanilloid 1 (TRPV1) channels and oxidative stress in the development and maintenance of pain associated with endometriosis” – Grant from Ministry of Health for young Researchers (GR-2018-12368352)
2024 - present
Principal Investigator “PerFert - Personalisation of Treatment for Female Infertility and Recurrent Pregnancy Loss of Unknown Ethiology”
Joint Transnational Call
for Proposals (2024) for “Identification or Validation of Targets for Personalised Medicine Approaches
(PMTargets)” - – EP PerMed.
Co-funded by The European Union.
HONORS AND AWARDS
- Premio Numana Madre e Feto 2016 - 1° Premioper la presentazione orale “Valutazione dell’outcome perinatale nelle gravidanze fisiologiche a termine insorte con PMA”
- Associate Faculty Member - Diabetes & Endocrinology – Reproductive Endocrinology & Infertility, Faculty Opinions
- Honorary memberof the Advisory Board of the Egyptian Foundation of Reproductive Medicine (EFRE)
PROFESSIONAL SOCIETY OR EXPERT GROUPS MEMBERSHIP
- Member Abnormal Uterine Bleeding (AUB) - Task Force - Society of Endometriosis and Uterine
Disorders (SEUD)
- Member Forum Group on Adenomyosis - Society of Endometriosis and Uterine Disorders (SEUD)
- Local Representative for the “International Society of Dietary Supplement and Phytotherapy”
- Member of the Expert Panel on Heavy Menstrual Bleeding (HELP Group), a panel of international physicians with an expert interest in HMB.
- International Society for Gynecological Endocrinology (ISGE) - member
- International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) - member
- Società Italiana di Ecografia Ostetrica e Ginecologica e Metodologie Biofisiche (SIEOG) - member
- Società Italiana di Medicina Perinatale (SIMP) - member
- Associazione Italiana Ginecologia Endocrinologica (AIGE) - member
PARTICIPATION - INTERNATIONAL CONGRESSES
Delivered 58 presentations at international conferences, courses, and masterclasses, 20 of which took place since 2023.
16-18/3/2023, Abu Dhabi, UAE
Invited speaker:
- “Abnormal Uterine Bleeding and uterine disorders: epidemiology, social and economic burden”
- “Heavy menstrual bleeding (HMB) and adolescence”
- Iron deficiency and anemia: Postpartum Hemorrhage
30/03/2023, Losanne, Switzerland
Invited speaker: “Adenomyosis & nulliparity: pain, bleeding and subfertility”
3-5/05/2023, Florence, Italy
Invited speaker: “Endometriosis and menopause”
15-16/05/2023, Rhyah, Saudi Arabia
Invited speaker: “Uterine fibroids and abnormal uterine bleeding”
1-2/06/2023, Cairo, Egypt
- Endometriosis recurrence: prediction, prevention and management
- Endometriosis and cancer: prevention and diagnosis
- Important aspects of gestational diabetes
25-28/06/2023, Copenhagen, Denmark
17-18/10/2023, Sevilla, Spain
Invited speaker: “The management of AUB”
16-17/11/2023, Porto, Portugal
Invited speaker: “Endometriosis: a new medical approach”
20-21/11/2023, Florence, Italy
Invited speaker: “Postpartum hemorrhage: uterine risk factors – a clinical case”
30/11/2023, Cairo, Egypt
Invited speaker: “Current concepts in adenomyosis”
1/12/2023, Amsterdam, The Netherlands
Invited speaker: “Differential diagnosis between uterine fibroids and adenomyosis”
20-21/01/2024, Dubai, UAE
- Update on comorbidities associated with endometriosis
- Menstrual distress as a medico-social dilemma
- Ultrasound criteria in diagnosing adenomyosis
Invited speaker: Recurrence of endometriosis and the need for long term treatment
18-20/04/2024, Geneve, Switzerland
Invited speaker: How to manage endometriosis associated co-morbidities - Gastrointestinal comorbidities
26/4/2024, Paris, France
Invited speaker: L’endométriose doit-elle être considérée comme une maladie
21-24/05/2024, India (online)
Invited speaker: “GnRH antagonists in gynecology: emerging role”
6-7/3/2025, Malaga, Spain
SEUD 2nd Masterclass: Current challenges and future solutions in endometriosis
Invited speaker: “Comorbidities and long-term consequences”
24-26/4/2025, Prague, Czech Republic
11th Annual SEUD Congress - From Adolescence to Menopause: Modern Management of Endometriosis and Uterine Diseases“
Invited speaker and Faculty member:
- “US and perimenopausal endometriosis”
- “Gynecological disorders and Young Age Women (YAW) athletes”
- “Endometriosis: understanding the benefits of correct medical treatment on patients’ lives”
- “Why early endometriosis diagnosis is essential?”
20/05/2025, online course
Invited speaker: “Fibroids in infertile women: role of ultrasound”
PUBLICATIONS
Bibliometric indicators H-Index 25
N citations: 3123 (Scopus)
Author of 112 articles published in peer-reviewed and indexed journals, 38 of which were published in the last three years.
The challenge of endometriosis for female sexual health.
Vannuccini S, Maseroli E, Vignozzi L, Petraglia F.
J Sex Med. 2023 Feb 27;20(3):240-246. doi: 10.1093/jsxmed/qdad004.
Epigenetics, endometriosis and sex steroid receptors: An update on the epigenetic regulatory mechanisms of estrogen and progesterone receptors in patients with endometriosis.
Rossi M, Seidita I, Vannuccini S, Prisinzano M, Donati C, Petraglia F.
Vitam Horm. 2023;122:171-191. doi: 10.1016/bs.vh.2023.01.007.
Endometriosis and the diagnosis of different forms of migraine: an association with dysmenorrhoea.
Pasquini B, Seravalli V, Vannuccini S, La Torre F, Geppetti P, Iannone L, Benemei S, Petraglia F.
Reprod Biomed Online. 2023 Apr 7:S1472-6483(23)00207-9. doi: 10.1016/j.rbmo.2023.03.020
Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set.
Cooper NAM, Rivas C, Munro MG, Critchley HOD, Clark TJ, Matteson KA, Papadantonaki R, Yorke S, Tan A, Bofill Rodriguez M, Bongers M, Al-Hendy A, Bahamondes L, Connolly A, Farquhar C, Gray Valbrun T, Hickey M, Taylor HS, Toub D, Vannuccini S, Iliodromiti S, Khan K.
BJOG. 2023 Oct;130(11):1337-1345. doi: 10.1111/1471-0528.17473.
The HOPE study: evaluating the impact of an online educational resource for heavy menstrual bleeding on the patient-physician dynamic.
Silva Filho AL, Catherino WH, Estrade JP, Koga K, Singh SS, Vannuccini S, Yang X, Lahav A, Caetano C, Calaf J.
Women Health. 2023 May-Jun;63(5):370-382. doi: 10.1080/03630242.2023.2220806.
The menstrual distress questionnaire (MEDI-Q): reliability and validity of the English version.
Cassioli E, Rossi E, Melani G, Faldi M, Rellini AH, Wyatt RB, Oester C, Vannuccini S, Petraglia F, Ricca V, Castellini G.
Gynecol Endocrinol. 2023 Jun 19;39(1):2227275. doi: 10.1080/09513590.2023.2227275.
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation.
Seidita I, Tusa I, Prisinzano M, Menconi A, Cencetti F, Vannuccini S, Castiglione F, Bruni P, Petraglia F, Bernacchioni C, Rovida E, Donati C.
FASEB J. 2023 Aug;37(8):e23061. doi: 10.1096/fj.202300323R.
A 10-Year Observational Study on Twin Pregnancy: Role of Fetal Sex Pairing on Obstetric Outcome.
Vannuccini S, Bolzonella S, Colucci C, Nicchi C, Strambi N, Di Tommaso M.
Twin Res Hum Genet. 2023 Sep 14:1-7. doi: 10.1017/thg.2023.38
Endometriosis and sexual disorders: the effect of surgical and medical treatment, a multicentre cross-sectional study.
Capezzuoli T, Maseroli E, Barra F, Vannuccini S, Vignozzi L, De Mitri P, Baggio S, Ceccaroni M, Petraglia F.
F1000Res. 2023 Oct 31;12:1424. doi: 10.12688/f1000research.141537.1.
Recurrence of Uterine Fibroids After Conservative Surgery or Radiological Procedures: a Narrative Review.
Capezzuoli T, Aslan B, Vannuccini S, Orlandi G, La Torre F, Sorbi F, Fambrini M, Petraglia F.
Reprod Sci. 2024 May;31(5):1171-1178. doi: 10.1007/s43032-023-01418-2
Sphingosine 1-phosphate signaling axis mediates neuropeptide S-induced invasive phenotype of endometriotic cells.
Prisinzano M, Bernacchioni C, Seidita I, Rossi M, Raeispour M, Cencetti F, Vannuccini S, Fambrini M, Petraglia F, Bruni P, Donati C.
FEBS J. 2024 Apr;291(8):1744-1758. doi: 10.1111/febs.17071.
Adenomyosis diagnosis among adolescents and young women with dysmenorrhoea and heavy menstrual bleeding.
Vannuccini S, Meleca C, Toscano F, Mertino P, Pampaloni F, Fambrini M, Bruni V, Petraglia F.
Reprod Biomed Online. 2024 May;48(5):103768. doi: 10.1016/j.rbmo.2023.103768.
An update for endometriosis management: a position statement.
Petraglia F, Vannuccini S, Santulli P, Marcellin L, Chapron C.
J Endometr Uter Disord. 2024 Jun;6: 100062. doi:10.1016/j.jeud.2024.100062
Abnormal uterine bleeding: The well-known and the hidden face.
Leal CRV, Vannuccini S, Jain V, Dolmans MM, Di Spiezio Sardo A, Al-Hendy A, Reis FM.
J Endometr Uterine Disord. 2024 Jun;6:100071. doi: 10.1016/j.jeud.2024.100071.
Imaging and molecular features of adenomyosis after menopause.
Vannuccini S, Gabbrielli S, Castiglione F, Nardi E, Rossi M, Orlandi G, Wu E, Bertoli F, Miele V, Donati C, Petraglia F.
Maturitas. 2024 Jul;185:107996. doi: 10.1016/j.maturitas.2024.107996.
The modern management of uterine fibroids-related abnormal uterine bleeding.
Vannuccini S, Petraglia F, Carmona F, Calaf J, Chapron C.
Fertil Steril. 2024 Jul;122(1):20-30. doi: 10.1016/j.fertnstert.2024.04.041.
Clinical signs and diagnosis of fibroids from adolescence to menopause.
Mension E, Carmona F, Vannuccini S, Chapron C.
Fertil Steril. 2024 Jul;122(1):12-19. doi: 10.1016/j.fertnstert.2024.05.003.
Conservative surgical treatment for adenomyosis: New options for looking beyond uterus removal.
Capezzuoli T, Toscano F, Ceccaroni M, Roviglione G, Stepniewska A, Fambrini M, Vannuccini S, Petraglia F.
Best Pract Res Clin Obstet Gynaecol. 2024 Jul;95:102507. doi: 10.1016/j.bpobgyn.2024.102507
An update on the management of uterine fibroids: personalized medicine or guidelines?
Mension E, Calaf J, Chapron C, Dolmans MM, Donnez J, Marcellin L, Petraglia F, Vannuccini S, Carmona F. J Endometr Uter Disord. 2024 Sept;7: 100080. doi:10.1016/j.jeud.2024.100080
Iron deficiency anemia: preconceptional, pregnancy and postpartum management – a call for action.
Petraglia F, Gallone A, Sieroszewski P, Pulanic D, Marton I, Calda P, Mikulasek L, Zdanowicz J, Belci D, Vannuccini S, Critchley H.
J Endometr Uter Disord. 2024 Sept;7:100079. doi:10.1016/j.jeud.2024.100079
Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosis.
Titiz M, Landini L, Souza Monteiro de Araujo D, Marini M, Seravalli V, Chieca M, Pensieri P, Montini M, De Siena G, Pasquini B, Vannuccini S, Iannone LF, Cunha TM, Brancolini G, Bellantoni E, Scuffi I, Mastricci A, Tesi M, Di Tommaso M, Petraglia F, Geppetti P, Nassini R, De Logu F.
Nat Commun. 2024 Nov;15(1):10142. doi: 10.1038/s41467-024-54486-6.
Long-term treatment for endometriosis with dienogest: efficacy, side effects and tolerability.
La Torre F, Vannuccini S*, Toscano F, Gallucci E, Orlandi G, Manzi V, Petraglia F.
Gynecol Endocrinol. 2024 Dec;40(1):2336121. doi: 10.1080/09513590.2024.2336121.
Menstrual distress in women with eating disorders: insights from the Menstrual Distress Questionnaire (MEDI-Q).
Rossi E, Cassioli E, Cordasco VZ, Caiati L, Rinaldo A, Tarchi L, Dani C, Vannuccini S, Petraglia F, Ricca V, Castellini G.
Arch Womens Ment Health. 2024 Nov 30. doi: 10.1007/s00737-024-01542-1.
Endometriotic lesions express microRNAs that potentially regulate the transcription of hydroxysteroid 17 beta dehydrogenase 2 (HSD17B2): a pilot study.
Coutinho LM, Bernacchioni C, Casalechi M, Vannuccini S, Francisco AMC, Petraglia F, Reis FM.
J Endometr Uter Disord. 2024 Dec;8:100093. doi:10.1016/j.jeud.2024.100093
Selective progesterone receptor modulators for the treatment of dysmenorrhea: an update.
Speciale AR, Ozpinar K, Giani M, Tureli D, Fambrini M, Vannuccini S, Petraglia F.
Expert Opin Pharmacother. 2025 Feb;26(3):257-264. doi: 10.1080/14656566.2025.2451145.
Elective uterine preservation: a novel concept to tackle reproductive ageing. Fertility preservation beyond ovaries.
Di Spiezio Sardo A, Becker CM, Vannuccini S, Verguts J, Estadella Tarriel J, Suvitie PA, Guerra S, Renner SP, Garcia Velasco JA.
Reprod Biomed Online. 2024 Nov 10;50(5):104704. doi: 10.1016/j.rbmo.2024.104704.
Diet characteristics in patients with endometriosis.
Ruotolo A, Vannuccini S, Capezzuoli T, Pampaloni F, Cecere S, Gallucci E, Petraglia F.
J Endometr Uter Disord. 2025 Mar;9:100094. doi:10.1016/j.jeud.2024.100094
Health related quality of life in individuals with endometriosis and mental health symptoms: a scoping review.
Colombo GE, Vijayanathan S, Breton Z, Kvaskoff M, Sediqzadah S, Vannuccini S, Sriranjan J, Jayesh T, Gholiof M, Leonardi M.
J Endometr Uter Disord. 2025 Mar;9:100105. doi:10.1016/j.jeud.2024.100105
Efficacy and safety of hormone therapies for treating adenomyosis-associated pelvic pain: a systematic review and network meta-analysis of randomized controlled trials.
Etrusco A, Agrifoglio V, D'Amato A, Chiantera V, Laganà AS, Haydamous J, Cobellis L, De Franciscis P, Vannuccini S, Krentel H, Naem A, Riemma G.
Front Endocrinol (Lausanne). 2025 Mar 17;16:1571727. doi: 10.3389/fendo.2025.1571727.
Management of women with endometriosis in the 21st century.
Di Spiezio Sardo A, Becker CM, Renner SP, Suvitie PA, Tarriel JE, Vannuccini S, Garcia Velasco JA, Verguts J, Mercorio A.
Curr Opin Obstet Gynecol. 2025 Apr 10;37(3):149-57. doi: 10.1097/GCO.0000000000001027
Human Leukocyte Antigen Haplotypes Predisposing to Celiac Disease in Patients With Endometriosis.
Vannuccini S, Manzi V, Tarocchi M, Donati N, La Torre F, Toscano F, Calabrò AS, Petraglia F.
Am J Reprod Immunol. 2025 Apr;93(4):e70079. doi: 10.1111/aji.70079.
Adenomyosis: the missed disease.
Santulli P, Vannuccini S, Bourdon M, Chapron C, Petraglia F.
Reprod Biomed Online. 2025 Apr;50(4):104837. doi: 10.1016/j.rbmo.2025.104837.
Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2.
Catherino WH, Al-Hendy A, Zaim S, Bouzegaou N, Venturella R, Stewart EA, Wu R, Vannuccini S, Perry JS, Rakov VG, Munro MG.
Fertil Steril. 2025 May 2:S0015-0282(25)00251-1. doi: 10.1016/j.fertnstert.2025.04.037.
Iron deficiency anemia and uterine disorders: impact on surgical management.
Arab H, Bukhari ME, Alkhamis WH, Albadawi IA, Al Shukri M, Angioni S, Chahine RH, Vannuccini S, Chapron C.
J Endometr Uter Disord. 2025 Jun;10:100112. doi:10.1016/j.jeud.2025.100112
Expression of cannabinoid receptors CB1, CB2 and GPR18 in adenomyotic lesions.
Prisinzano M, Raeispour M, Rossi M, Seidita I, Vannuccini S, Fambrini M, Nardi E, Castiglione F, Petraglia F, Bernacchioni C, Donati C.
J Endometr Uter Disord. 2025 Jun;10: 100111. doi:10.1016/j.jeud.2025.100111
Medical treatment for adenomyosis: long term use of progestins.
Vannuccini S, La Torre F, Toscano F, Speciale AR, Giani M, Tureli D, Manzi V, Gallone A, Petraglia F.
Gynecol Endocrinol. 2025 Dec;41(1):2511329. doi: 10.1080/09513590.2025.2511329.
Systemic comorbidities in patients with adenomyosis.
Gallone A, Vannuccini S*, Manzi V, La Torre F, Toscano F, Giani M, Fambrini M, Chedraui P, Petraglia F. Reprod Biomed Online. 2025. doi:10.1016/j.rbmo.2025.02.015
Endometriosis and fibromyalgia co occurrence: a comparative study of patient history and clinical profile.
Manzi V, Vannuccini S, Nacci F, Mauro I, Gallone A, Giani M, Guiducci S, Petraglia F.
J Endometr Uter Disord. 2025;11. doi:10.1016/j.jeud.2025.100107
EDITORIAL ACTIVITY
Editorial Board Member
Reproductive Health (Associate Editor)
Journal of Endometriosis and Pelvic Pain Disorders (Editorial Board Member)
Clinical and Experimental Obstetrics & Gynecology (Associate Editor)
Frontiers in Reproductive Health (Guest Associate Editor)
Frontiers in Gynecology (Review Editor)
Frontiers in Developmental Endocrinology (Review Editor)
Journal of Endometriosis and Uterine Disorders (JEUD) (Editorial Board Member)
Scientific Reviewer
Publons Web of Science Researcher ID J-8927-2019
- Gynecological and Reproductive Endocrinology & Metabolism
- Journal of Physiology and Biochemistry
Languages
Endometriosis
Uterine Adenomyosis
Uterine Fibroids
Imaging and ultrasound in gynecology
Hormonal Therapies
Menstruation and Quality of Life
Maternal High-Risk Pregnancy
Preconception Counseling